MCQOPTIONS
Saved Bookmarks
| 1. |
Concerning the prophylactic use of G-CSF during cancer chemotherapy: |
| A. | it decreases the duration of neutropenia |
| B. | it decreases the severity of the neutropenic nadir |
| C. | it increases platelet numbers |
| D. | it potentiates the effect of chemotherapy |
| E. | it is only useful in established neutropenia |
| Answer» C. it increases platelet numbers | |